COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,693 Articles (22,913 medRxiv, 8,780 bioRxiv)

Most recent first Previous |  Page 1549: Articles 15481-15490  | Next

Evaluation of mRNA-1273 against SARS-CoV-2 B.1.351 Infection in Nonhuman Primates
Corbett, K. S., Werner, A., O'Connell, S., Gagne, M., Lai, L., Moliva, J., Flynn, B., Choi, A., Koch, M., Foulds, K. E., Andrew, S., Flebbe, D., Lamb, E., Nurmukhambetova, S. T., Provost, S., Bock, K. W., Minai, M., Nagata, B. M., Van Ry, A., Flinchbaugh, Z., Johnston, T. S., Bayat Mokhtari, E., Mudvari, P., Henry, A. R., Laboune, F., Chang, B., Porto, M., Wear, J., Alvarado, G. S., Boyoglu-Barnum, S., Todd, J.-P., Bart, B., Cook, A., Dodson, A., Pessaint, L., Steingrebe, K., Elbashir, S., Andersen, H., Wu, K., Edwards, D. K., Kar, S., Lewis, M. G., Boritz, E., Moore, I., Carfi, A., Suthar, M., McDermott, A., Roederer, M., Nason, M. C., Sullivan, N. J., Douek, D. C., Graham, B. S., Seder, R. A.
10.1101/2021.05.21.445189 — Posted: 2021-05-24
Interplay between protein stability, binding to ACE2 and escape from neutralizing antibodies determines the natural selection of SARS-CoV-2 receptor binding domain variants
Upadhyay, V., Lucas, A., Panja, S., Mallela, K.
10.1101/2021.05.23.445348 — Posted: 2021-05-24
Unsupervised explainable AI for the collective analysis of a massive number of genome sequences: various examples from the small genome of pandemic SARS-CoV-2 to the human genome
Ikemura, T., Iwasaki, Y., Wada, K., Wada, Y., Abe, T.
10.1101/2021.05.23.445371 — Posted: 2021-05-24
The COVID in the Context of Pregnancy, Infancy and Parenting (CoCoPIP) Study: protocol for a longitudinal study of parental mental health, social interactions, physical growth, and cognitive development of infants during the pandemic.
Aydin, E., Weiss, S. M., Glasgow, K. A., Barlow, J., Austin, T., Johnson, M. H., Lloyd-Fox, S.
10.1101/2021.05.22.21257649 — Posted: 2021-05-24
Effectiveness of COVID-19 vaccines against the B.1.617.2 variant
Lopez Bernal, J., Andrews, N., Gower, C., Gallagher, E., Simmons, R., Thelwall, S., Tessier, E., Groves, N., Dabrera, G., Myers, R., Campbell, C., Amirthalingam, G., Edmunds, M., Zambon, M., Brown, K., Hopkins, S., Chand, M., Ramsay, M.
10.1101/2021.05.22.21257658 — Posted: 2021-05-24 Discussion: Onsite | Offsite
Attitudes Toward The COVID-19 Vaccine Among North Carolina Participants In The COVID-19 Community Research Partnership
Enwezor, C., Peacock, J. E., Edelstein, S. L., Hinkelman, A. N., Seals, A. L., Wierzba, T. F., Munawar, I., Runyon, M. S., Magurie, P. D., Lagarde, W. H., Gibbs, M. A., Gallaher, T. R., Sanders, J. W., herrington, d.
10.1101/2021.05.20.21257343 — Posted: 2021-05-24
EVALUATION OF A RAPID ANTIGEN TEST FOR SARS-COV-2 IN SYMPTOMATIC PATIENTS AND THEIR CONTACTS: A MULTICENTER STUDY
THIRION-ROMERO, I., GUERRERO-ZUNIGA, S., ARIAS-MENDOZA, A., CORNEJO-JUAREZ, D. P., MEZA-MENESES, P., TORRES-ERAZO, D. S., Hernandez-Gilsoul, T., Galindo-Fraga, A., Villegas-Mota, I., Sepulveda -Delgado, J., Avila-Rios, S., Becerril-Vargas, E., FERNANDEZ-PLATA, R., Perez-Kawabe, M., Vazquez-Perez, J. A., KAWA-KARASIK, S., REYES-TERAN, G., Perez-Padilla, R.
10.1101/2021.05.24.21257020 — Posted: 2021-05-24
Retrospective screening for SARS-CoV-2 among 5,800 hospitalizations related to influenza-like illness during the 2018-19 pre-pandemic and 2019-2020 pandemic influenza seasons in the VAHNSI network, Spain.
Mira Iglesias, A., Mengual-Chulia, B., Cano-Perez, L., Garcia Rubio, J., Tortajada-Girbes, M., Carballido-Fernandez, M., Mollar-Maseres, J., Schwarz-Chavarri, G., Garcia Esteban, S., Puig Barbera, J., Diez-Domingo, J., Lopez-Labrador, F. X., Valencia Hospital Network for the Study of Influenza and Respiratory Viruses Disease
10.1101/2021.05.24.21257402 — Posted: 2021-05-24
ACTIVATE-2: A DOUBLE-BLIND RANDOMIZED TRIAL OF BCG VACCINATION AGAINST COVID19 IN INDIVIDUALS AT RISK
Tsilika, M., Taks, E., Dolianitis, K., Kotsaki, A., Leventogiannis, K., Damoulari, C., Kostoula, M., Paneta, M., Adamis, G., Papanikolaou, I. C., Stamatelopoulos, K., Bolanou, A., Katsaros, K., Delavinia, C., Perdios, I., Pandi, A., Tsiakos, K., Proios, N., Kalogianni, E., Delis, I., Skliros, E., Akinosoglou, K., Perdikouli, A., Poulakou, G., Milionis, H., Athanasopoulou, E., Kalpaki, E., Efstratiou, L., Perraki, V., Papadopoulos, A., Netea, M. G., Giamarellos-Bourboulis, E.
10.1101/2021.05.20.21257520 — Posted: 2021-05-24 Discussion: Onsite
Efficacy and safety of novel probiotic formulation in adult Covid19 outpatients: a randomized, placebo-controlled clinical trial
Gutierrez-Castrellon, P., Gandara-Marti, T., Abreu y Abreu, A. T., Nieto-Rufino, C. D., Lopez-Orduna, E., Jimenez-Escobar, I., Jimenez-Gutierrez, C., Lopez-Vazquez, G., Espadaler-Mazo, J.
10.1101/2021.05.20.21256954 — Posted: 2021-05-24

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).